Page last updated: 2024-09-05

oxypressin and arginine vasopressin

oxypressin has been researched along with arginine vasopressin in 5 studies

Compound Research Comparison

Studies
(oxypressin)
Trials
(oxypressin)
Recent Studies (post-2010)
(oxypressin)
Studies
(arginine vasopressin)
Trials
(arginine vasopressin)
Recent Studies (post-2010) (arginine vasopressin)
70012,2784221,212

Protein Interaction Comparison

ProteinTaxonomyoxypressin (IC50)arginine vasopressin (IC50)
Vasopressin V2 receptorHomo sapiens (human)0.242

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ala, Y; Balestre, MN; Chini, B; Elands, J; Hibert, M; Hoflack, J; Jard, S; Manning, M; Mouillac, B; Trumpp-Kallmeyer, S1
Andriolo, M; Balestre, MN; Barberis, C; Chini, B; Hibert, M; Hoflack, J; Jard, S; Mouillac, B; Pupier, S; Trumpp-Kallmeyer, S1
Gazis, D1
Gazis, D; Gonzalez, G; Mendlowitz, M1
Fahrenholz, F; Kojro, E; Postina, R1

Other Studies

5 other study(ies) available for oxypressin and arginine vasopressin

ArticleYear
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
    The EMBO journal, 1995, May-15, Volume: 14, Issue:10

    Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Binding Sites; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Oligopeptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Signal Transduction; Structure-Activity Relationship

1995
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.
    FEBS letters, 1996, Nov-18, Volume: 397, Issue:2-3

    Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Cell Line; Cloning, Molecular; Computer Simulation; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxytocin; Receptors, Oxytocin; Vasotocin

1996
In vivo apparent peptide-receptor dissociation rate constants for arginine vasopressin analogs estimated from inhibition of rat pressor responses.
    Canadian journal of physiology and pharmacology, 1987, Volume: 65, Issue:10

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Computer Simulation; Female; Half-Life; Kinetics; Oxytocin; Rats; Receptors, Cell Surface; Vasopressins; Vasotocin

1987
Verapamil blockade of pressor and uterine responses to AVP-OT analogue, oxypressin.
    The American journal of physiology, 1988, Volume: 254, Issue:1 Pt 2

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Female; Oxytocin; Rats; Uterine Contraction; Uterus; Verapamil

1988
Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor.
    The Journal of biological chemistry, 1996, Dec-06, Volume: 271, Issue:49

    Topics: Affinity Labels; Amino Acid Sequence; Animals; Arginine Vasopressin; Binding Sites; Molecular Sequence Data; Oxytocin; Protein Conformation; Receptors, Oxytocin; Receptors, Vasopressin; Swine; Vasotocin

1996